| |
| ...your preferred-provider of state-of-the-art research reagents | |
|
BioProducts MD specializes in the development, marketing, and sales of exciting new bioproducts of interest to the biotechnology and pharmaceutical industries. |
![]() |
Elvitegravir-Resistant HIV-1 (N155H) BioProducts MD adds another important reagent to its product portfolio to facilitate the development of therapeutic agents targeting drug-resistant HIV. The HIV integrase N155H mutation confers resistance to Elvitegravir and partial resistance to Raltegravir. This drug-resistant enzyme will facilitate identification of new therapeutic agents possessing favorable antiviral activity against this drug resistance-engendering mutation. | ||
|
Click here for detailed information on our new HIV Integrase (N155H) drug-resistant mutant enzyme | |||
| |||
| Click here for detailed information on the PEDF ELISA | |||